+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cannabidiol"

CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 898 Pages
  • Global
From
From
Sleeping Aids - Global Strategic Business Report - Product Thumbnail Image

Sleeping Aids - Global Strategic Business Report

  • Report
  • March 2025
  • 196 Pages
  • Global
From
From
From
From
Sturge-Weber Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Sturge-Weber Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Dravet Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Dravet Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
From
From
Fragile X Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Fragile X Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • May 2024
  • 60 Pages
  • Global
From
Medical Marijuana - Cannabidiol - Pipeline Insight, 2024 - Product Thumbnail Image

Medical Marijuana - Cannabidiol - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Systemic Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Doose Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Doose Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Seizures Pipeline Insight Analysis Report - Product Thumbnail Image

Seizures Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
Loading Indicator

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease. CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions. The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more